drugset / Trial / NCT00694564
Evaluation of S-adenosyl Methionine (SAM-e) for Recurrent Abdominal Pain in Children
NaSingle-groupOpen-labelTreatment
Summary
This pilot study will investigate the efficacy of SAM-e for the treatment of recurrent abdominal pain in children. This will be an open-labeled study and all participants will receive SAM-e therapy. Given that SAM-e has been demonstrated to improve symptoms of depression and pain with minimal side effects as compared to other antidepressant therapy, we hypothesize that SAM-e will reduce pain symptoms among children with recurrent abdominal pain.
Timeline
- Start
- 2007-06
- Primary completion
- 2011-03
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S-adenosylmethionine | Other / unclassified | 200 mg | — |
| Subject | S-adenosylmethionine | Other / unclassified | 1400 mg | — |
Indications
No indication recorded.